SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading GALE News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-8.47%||81.05||1.6%||$900.38m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.85%||398.27||3.1%||$310.67m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.64%||126.65||2.6%||$251.29m|
|BMRN||BioMarin Pharmaceutical Inc.||-0.83%||92.02||3.9%||$191.14m|
|VRTX||Vertex Pharmaceuticals Incorporated||-0.83%||94.98||1.7%||$133.87m|
|JUNO||Juno Therapeutics, Inc.||4.09%||30.52||7.9%||$106.65m|
|A||Agilent Technologies, Inc.||1.73%||46.94||1.9%||$94.77m|
|EXAS||Exact Sciences Corporation||30.10%||16.21||28.8%||$87.72m|
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Its development portfolio ranges from mid to late stage clinical assets which include program led by NeuVax. The company's commercial drugs include Abstral (fentanyl) Sublingual Tablets and Zuplenz (ondansetron) Oral Soluble Film. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Galena Biopharma was founded by Craig Mello on April 3, 2006 and is headquartered in Portland, OR.